StockDuty ← Dashboard Nov 13, 2026 04:05 AM ET
SignalCorporate

Hansa Biopharma GAAP EPS of -$1.75, revenue of $143M

Hansa Biopharma reported GAAP EPS of -$1.75 and revenue of $143M.

What happened: Hansa Biopharma reported third quarter GAAP EPS of -SEK1.75 and revenue of SEK143M. Key numbers: Q3 GAAP EPS -SEK1.75. Revenue SEK143M, up 364.3% Y/Y from SEK30.8M in the prior year period. Why it matters: The revenue increase was primarily driven by revenue recognized under the license agreement with SERB Pharmaceuticals. Coverage: 6 outlets in 24h
Hansa Biopharma reported third quarter GAAP EPS of -SEK1.75 and revenue of SEK143M.
The revenue increase was primarily driven by revenue recognized under the license agreement with SERB Pharmaceuticals.
Sources